Business Description
Guard Therapeutics International AB
ISIN : SE0021181559
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.81 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 2.5 | |||||
3-Year EPS without NRI Growth Rate | 2.5 | |||||
3-Year FCF Growth Rate | -0.2 | |||||
3-Year Book Growth Rate | -29.2 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.43 | |||||
9-Day RSI | 38.1 | |||||
14-Day RSI | 38.82 | |||||
6-1 Month Momentum % | 28.32 | |||||
12-1 Month Momentum % | -12.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.28 | |||||
Quick Ratio | 5.28 | |||||
Cash Ratio | 5.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.2 | |||||
Shareholder Yield % | -14.66 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -102.76 | |||||
ROA % | -82.12 | |||||
ROIC % | -771.73 | |||||
ROC (Joel Greenblatt) % | -1072281.82 | |||||
ROCE % | -101.01 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.88 | |||||
Price-to-Tangible-Book | 3.88 | |||||
EV-to-EBIT | -2.74 | |||||
EV-to-EBITDA | -2.74 | |||||
EV-to-FCF | -2.67 | |||||
Price-to-Net-Current-Asset-Value | 3.88 | |||||
Price-to-Net-Cash | 3.95 | |||||
Earnings Yield (Greenblatt) % | -36.5 | |||||
FCF Yield % | -26.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Guard Therapeutics International AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -8.033 | ||
Beta | 2.15 | ||
Volatility % | 94.21 | ||
14-Day RSI | 38.82 | ||
14-Day ATR (kr) | 1.630044 | ||
20-Day SMA (kr) | 27.32 | ||
12-1 Month Momentum % | -12.12 | ||
52-Week Range (kr) | 16 - 46 | ||
Shares Outstanding (Mil) | 12.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guard Therapeutics International AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guard Therapeutics International AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Guard Therapeutics International AB Frequently Asked Questions
What is Guard Therapeutics International AB(OSTO:GUARD)'s stock price today?
When is next earnings date of Guard Therapeutics International AB(OSTO:GUARD)?
Does Guard Therapeutics International AB(OSTO:GUARD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |